|Articles|April 10, 1996

SMV's attenuation correction cleared

Nuclear medicine vendor SMV of Twinsburg, OH, has announced thatthe Food and Drug Administration has issued 510(k) clearance forits transmission attenuation correction (TAC) protocol. TAC isdesigned for SMV's Vision DST and Vision DST-XL

Nuclear medicine vendor SMV of Twinsburg, OH, has announced that

the Food and Drug Administration has issued 510(k) clearance for

its transmission attenuation correction (TAC) protocol. TAC is

designed for SMV's Vision DST and Vision DST-XL variable-angle

gamma cameras.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Subscribe Now!

Latest CME

Video

Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | Texas

Jeremie Calais, MD, PhD; Qian Qin, MD

SMV's attenuation correction cleared

Newsletter

Related Content

The Move Toward More Comprehensive Screening with Computed Tomography: An Interview with David Yankelevitz, MD

AI-Enhanced CT Platform for Radiation Oncologists Gets FDA Nod

Radiology Roundup of New FDA Clearances: January 11 — January 17

Diagnostic Imaging's Weekly Scan: January 11 — January 17

A Closer Look at Automated LLM Protocoling for Abdominal and Pelvic CT

Latest CME

Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | Texas

Inaugural Brain & Spine Metastases Conference: Evolving Practice and Emerging Therapies

2nd Annual Hawaii Cancer Conference

23rd Annual Winter Lung Cancer Conference®

43rd Annual Miami Breast Cancer Conference®

19th Annual New York GU Cancers Congress™

Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies

Cases and Conversations™: Redefining Treatment Pathways in Low-Grade Serous Ovarian Cancer

Cases & Conversations™: Expert Perspectives on Leveraging Recent Advances to Transform SCLC Treatment

Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

17th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice

PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC—Expert Perspectives on New Approvals and Emerging Strategies

Radioligand Therapy 101: The Science Behind the Strategy

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

2026 International Symposium of Gastrointestinal Oncology (ISGIO)

26th Annual International Lung Cancer Congress

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

44th Annual CFS®: Innovative Cancer Therapy for Tomorrow™

21st Annual New York Lung Cancers Symposium®

9th Annual School of Nursing Oncology™

Trending on Diagnostic Imaging

AI-Enhanced CT Platform for Radiation Oncologists Gets FDA Nod

Seven Takeaways from New Review of Common Mammography Misses

Looking Beyond The Generic Radiology Job Tease

The Move Toward More Comprehensive Screening with Computed Tomography: An Interview with David Yankelevitz, MD

Radiology Roundup of New FDA Clearances: January 11 — January 17